ORBIMED ADVISORS LLC 13D and 13G filings for Sionna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:47 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
ORBIMED ADVISORS LLC | 3,704,959 8.400% |
3,704,959 (New Position) |
Filing |